SCHEMBL650947

SCHEMBL650947

O=S(=O)(Nc1ccccc1Sc1ccccc1)C(F)(F)F

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 7/20 0.70
PTGS2 P35354 6/20 0.70
CA2 P00918 1/20 0.51
MAPT P10636 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
ALDH1A1 P00352 5/20 0.45
HPGD P15428 2/20 0.45
L3MBTL1 Q9Y468 4/20 0.44
GLA P06280 1/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
BLM P54132 1/20 0.44
LMNA P02545 1/20 0.43
ATM Q13315 1/20 0.43
MAPK1 P28482 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31373266 1.00 PTGS1 (0.70) PTGS1PTGS2CA2MAPTTDP1
SCHEMBL21786210 0.78 PTGS1 (0.68) PTGS1PTGS2MAPTTDP1ALDH1A1
SCHEMBL11180141 0.78 PTGS2 (0.55) PTGS1PTGS2CA2
SCHEMBL28027003 0.77 PTPN1 (0.54) PTGS1PTGS2CA2MAPTALDH1A1
SCHEMBL21786248 0.74 SLC22A12 (0.48) PTGS1PTGS2MAPTTDP1ALDH1A1
SCHEMBL4968060 0.73 PTGS1 (0.50) PTGS1PTGS2CA2KMT2AMEN1
SCHEMBL12054691 0.72 CA2 (0.66) PTGS1PTGS2CA2MAPTKMT2A
SCHEMBL10622905 0.72 CA2 (0.61) PTGS1PTGS2CA2SMN1; SMN2
SCHEMBL6517495 0.71 CA2 (0.56) PTGS1PTGS2CA2ALDH1A1L3MBTL1
SCHEMBL4972432 0.71 PTGS1 (0.70) PTGS1PTGS2CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239759-A1 ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS INTERVET INC. (US) 2024-07-18 US disclosed
CN-117986154-A Antiparasitic compounds 英特维特国际股份有限公司 2024-05-07 CN disclosed
US-20240043446-A1 ANTHELMINTIC COMPOUNDS COMPRISING A THIENOPYRIDINE STRUCTURE INTERVET INC. (US) 2024-02-08 US disclosed
US-20240043385-A1 ANTHELMINTIC COMPOUNDS COMPRISING A PYRIDINE STRUCTURE INTERVET INC. (US) 2024-02-08 US disclosed
EP-4284509-A1 ANTIPARASITIC COMPOUNDS Intervet International B.V. (NL) 2023-12-06 EP disclosed
CN-116964031-A Antiparasitic compounds 英特维特国际股份有限公司 2023-10-27 CN disclosed
US-20230148316-A1 ANTHELMINTIC COMPOUNDS COMPRISING A QUINOLINE STRUCTURE INTERVET INC. (US) 2023-05-11 US disclosed
US-20230110397-A1 ANTHELMINTIC COMPOUNDS COMPRISING AZAINDOLES STRUCTURE INTERVET INC. (US) 2023-04-13 US disclosed
EP-2545777-B2 Use of an isoxazoline composition as antiparasitic INTERVET INT BV (NL) 2023-01-18 EP disclosed
CN-114846014-A Insect repellent compounds comprising azaindole structures 英特维特国际股份有限公司 2022-08-02 CN disclosed
US-20070238700-A1 N-PHENYL-1,1,1-TRIFLUOROMETHANESULFONAMIDE HYDRAZONE DERIVATIVE COMPOUNDS AND THEIR USAGE IN CONTROLLING PARASITES SCHERING-PLOUGH LTD. (CH) 2007-10-11 US disclosed
WO-2007079010-A2 CARBONATES OF FENICOL ANTIBIOTICS SCHERING-PLOUGH LTD. (CH) 2007-07-12 WO disclosed
US-20070155799-A1 CARBONATES OF FENICOL ANTIBIOTICS INTERVET INC. 2007-07-05 US disclosed
EP-1799636-A2 CONTROL OF PARASITES IN ANIMALS BY THE USE OF NOVEL TRIFLUOROMETHANESULFONANILIDE OXIME ETHER DERIVATIVES Schering-Plough Ltd. (CH) 2007-06-27 EP disclosed
WO-2006135648-A2 CONTROL OF PARASITES IN ANIMALS BY N-[(PHENYLOXY)PHENYL]-1,1,1-TRIFLUOROMETHANESULFONAMIDE AND N-[(PHENYLSULFANYL)PHENYL]-1,1,1-TRIFLUOROMETHANESULFONAMIDE DERIVATIVES SCHERING-PLOUGH LTD. (CH) 2006-12-21 WO disclosed
US-20060281695-A1 Control of parasites in animals by N-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide and N-[(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide derivatives SCHERING-PLOUGH ANIMAL HEALTH CORPORATION 2006-12-14 US disclosed
US-20060281695-A1 Control of parasites in animals by N-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide and N-[(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide derivatives SCHERING-PLOUGH ANIMAL HEALTH CORPORATION 2006-12-14 US disclosed
US-20060128779-A1 Control of parasites in animals by the use of parasiticidal 2-phenyl-3-(1H-pyrrol-2-yl)acrylonitrile derivatives SCHERING-PLOUGH ANIMAL HEALTH CORPORATION 2006-06-15 US disclosed
WO-2006034333-A2 CONTROL OF PARASITES IN ANIMALS BY THE USE OF NOVEL TRIFLUOROMETHANESULFONANILIDE OXIME ETHER DERIVATIVES SCHERING-PLOUGH LTD. (CH) 2006-03-30 WO disclosed
US-20060063841-A1 Parasiticides; nematocides; crop protection SCHERING-PLOUGH LTD. (CH) 2006-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240043385-A1 ANTHELMINTIC COMPOUNDS COMPRISING A PYRIDINE STRUCTURE HRH4, PNPO, NME4 PTGS1 450/4885PTGS2 533/4885CA2 4085/4885
US-20060128779-A1 Control of parasites in animals by the use of parasiticidal 2-phenyl-3-(1H-pyrrol-2-yl)acrylonitrile derivatives PNN, AADAC, EPX PTGS1 460/4885PTGS2 185/4885CA2 2920/4885
US-20070155799-A1 CARBONATES OF FENICOL ANTIBIOTICS CYP4F3, TET1, CYP4F2 PTGS1 589/4885PTGS2 1206/4885CA2 15/4885
US-20240043446-A1 ANTHELMINTIC COMPOUNDS COMPRISING A THIENOPYRIDINE STRUCTURE DHODH, NISCH, DDT PTGS1 177/4885PTGS2 187/4885CA2 4003/4885
US-20060063841-A1 Parasiticides; nematocides; crop protection TRHDE, DDT, EPHX1 PTGS1 1332/4885PTGS2 1406/4885CA2 2220/4885
US-20230148316-A1 ANTHELMINTIC COMPOUNDS COMPRISING A QUINOLINE STRUCTURE DHX35, DDX5, DHODH PTGS1 806/4885PTGS2 698/4885CA2 4051/4885
US-20060281695-A1 Control of parasites in animals by N-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide and N-[(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide derivatives ELANE, CTRL, PIGO PTGS1 296/4885PTGS2 1435/4885CA2 3839/4885
US-20230110397-A1 ANTHELMINTIC COMPOUNDS COMPRISING AZAINDOLES STRUCTURE AADAC, HNMT, NISCH PTGS1 1492/4885PTGS2 1123/4885CA2 4427/4885
US-20240239759-A1 ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS PRDX5, TUBA3C, TUBA1C PTGS1 1988/4885PTGS2 1369/4885CA2 651/4885
US-20070238700-A1 N-PHENYL-1,1,1-TRIFLUOROMETHANESULFONAMIDE HYDRAZONE DERIVATIVE COMPOUNDS AND THEIR USAGE IN CONTROLLING PARASITES NAT1, NGLY1, ELANE PTGS1 243/4885PTGS2 1608/4885CA2 2100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.